• 2014
DBA KRISHGEN BIOSYSTEMS USA set up in Los Angeles, CA, US.
  • 2015
GENLISA Cytokine ELISA kits launched in India, Asia as alternate to offer budgeted solutions to the researcher
  • 2016
Product Development and Commercialization of Reagents initiated at India operations. KRIBIOLISA Assay Kits for Therapeutic Monitoring and Immunogenicity launched.
  • 2017
ELISA kits for Therapeutic Peptides and Vaccines Monitoring developed. The world's first PLCgamma2 Tyr759/1217 ELISA kit developed.
  • 2018
CE Mark obtained for Biomonitoring KRIBIOLISA ELISA kits. Participated in 1st International Exhibition in Medica 2018, Dusseldorf, Germany.
With the outbreak of Nipah Virus in India, KRISHGEN develops and commercialize using recombinant antibodies, the world's first Nipah Virus ELISA kit.
  • 2019
International Distributor network initiated to offer KRISHGEN reagents and kits in over 14 countries worldwide.

200+

Happy Client

750+

Cups of Coffee

1800+

Projects Done

15+

Office Locations

Enquire

Testimonials

ARE YOU A DISTRIBUTOR

Join KRISHGEN as a verified distributor to get access to over 1 million sku’s, including reagents, biochemicals and assays. Your one stop vendor for life sciences.

Subscribe Newsletter

WE ALSO DISTRIBUTE SPECIFICALLY IN ASIA INCL. INDIA FOR

Krishgen Support